XRP Healthcare AMA Recap with CEO Kain Roomes – June 14, 2025

Date: June 14, 2025
Time: 8 PM UTC
Host: Corey
Guest: Kain Roomes, CEO of XRP Healthcare

Welcome & Opening Remarks

Corey:
Welcome, everyone, to this exclusive AMA with Kain Roomes, CEO of XRP Healthcare!
We’re thrilled to have you join us for what promises to be an insightful session.

Here’s how tonight went down:

• We started with pre-submitted questions from the community

• Kain answered them live

• We closed with a few live chat questions (as time allowed)

Let’s jump into the key takeaways.

Community Q&A Highlights

Q1: Are XRPH tokens being sold to fund the IPO?

Kain: Absolutely not. The IPO, via our RTO listing on the TSXV, is funded through traditional private capital – not through token sales.

Q2: Will $XRPH still be central after the IPO?

Kain: That’s our intention. XRPH powers utility, engagement, and alignment today – and post-IPO, we plan to deepen its role via integrations with pharmacies, access features, and services.

Q3: How will the XRPH AI app be monetized?

Kain: Through fiat-based subscription plans, in-app purchases, brand sponsorships, and healthcare integrations. XRPH tokens are not required for access.

Q4: Was there a seed or private sale?

Kain: No private sale. A public token sale occurred on the Sologenic DEX (Dec 2022 – Jan 2023). Founder allocations were structured with vesting and controls.

Q5: Can token holders get IPO access?

Kain: No. IPO access is regulated under Canadian securities law and cannot be tied to token holdings. That said, we’re exploring other ways to reward the XRPH community.

Q6: Why is XRPH listed on few exchanges?

Kain: Tier 1 listings are costly. We’re preserving long-term value by prioritizing real growth (M&A, product rollout, IPO) over hype. Strategic listings will come in time.

Q7: Any plans to reduce token supply?

Kain: XRPH has a fixed supply and no inflation. While no burn is active, supply optimization may be explored depending on adoption and legal guidance.

Q8: What’s coming post-IPO?

Kain: Major milestones include more pharmacy acquisitions, a global XRPH AI App rollout, Series A fundraising, and expanding across Africa and other markets.

Q9: Has the company undergone audits for TSXV?

Kain: Yes. A full audit of Pharma Ville (our acquired group) covering 2022–2024 was completed and submitted. All regulatory checks and due diligence have been cleared.

Q10: Is XRPH seeing real utility today?

Kain: Yes. It’s already being used for payments in our Ugandan pharmacies. As our network grows, so will organic demand.

Q11: Will there be global token marketing?

Kain: Yes – and it’s already underway. We’ve outperformed many projects in real-world exposure. Post-IPO, expect even more targeted campaigns.

Q12: How does the IPO benefit the token?

Kain: Public listing brings global visibility, investor attention, and new users into the ecosystem – increasing utility and engagement via the XRPH token.

Q13: What’s XRPH’s long-term role?

Kain: It will remain a utility token – powering healthcare access, payments, and potential loyalty and rewards mechanisms.

Q14: Will influencers or campaigns be involved?

Kain: Absolutely. Influencer partnerships and healthcare-centric campaigns are in the roadmap, especially post-AI app expansion.

Q15: What’s the current stage of the RTO process?

Kain: We’ve signed the Letter of Intent and are finalizing documentation. The Definitive Agreement and final TSXV steps are underway.

Q16: Any expansion plans beyond Africa?

Kain: Yes. Dubai, the Middle East, and Europe are next. We’ve secured trademarks across the UK, UAE, and all 27 EU countries.

Q17: What regulatory milestones have been hit?

Kain: We’re licensed in the UAE and fully operational in Uganda. All TSXV audit and compliance requirements have been met.

Q18: What is ARC Group’s involvement?

Kain: ARC Group is our financial advisor for the TSXV listing. They’ve helped shape valuation and strategy but hold no equity.

Q19: How many employees are at XRP Healthcare?

Kain: A lean team in Dubai, pharmacy staff in Uganda, and a global network of consultants across legal, M&A, and development.

Q20: What’s XRPH’s use now that a stock is coming?

Kain: The stock supports corporate growth. The token supports community and service-level engagement – including payments, discounts, and app access.

Closing Remarks

Corey:
That wraps up our AMA with Kain Roomes!
A huge thank-you to Kain for the transparency and updates, and to all of you for being here.

Be sure to follow XRP Healthcare for more updates as they move toward their public listing and continue expanding their healthcare ecosystem.